Contents
pdf Download PDF pdf Download XML
70 Views
22 Downloads
Share this article
Research Article | Volume 10 Issue 3 (None, 2016) | Pages 62 - 66
Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab.
 ,
 ,
 ,
 ,
 ,
 ,
Under a Creative Commons license
Open Access
PMID : PMC4619161
Received
Nov. 13, 2013
Published
Sept. 30, 2015
Abstract

Background:Pyoderma gangraenosum is an immune-mediated, inflammatory, neutrophilic dermatosis of unknown etiology, which represents one of the extraintestinal manifestations of inflammatory bowel disease. It is a rare disease that occurs in less than 1% of patients with inflammatory bowel disease and with the same ratio in patients with Crohn's disease and ulcerative colitis.Main observations:A 36-year-old woman was diagnosed with ulcerative colitis 6 years before admission to our dermatology department with an acute disseminated pyoderma gangraenosum with mucosal involvement, during a flare of ulcerative colitis. Disease progression was interrupted by intravenous administration of the tumor necrosis factor-α inhibitor infliximab at 5 mg/kg at weeks 0, 2, and 6 (1st cycle) and every 8 weeks thereafter. Improvement of intestinal, skin and oral manifestations was evident already after the 1st cycle of treatment and has been maintained since (at least 16 months).Conclusions:This case report is one of very few on disseminated pyoderma gangraenosum with oral involvement complicating ulcerative colitis, where infliximab was shown to have a rapid efficacy on skin, mucosal and bowel symptoms.

Keywords
Recommended Articles
Research Article
Impact of COVID-19 on Sexually Transmitted Infection Burden: A Cross-Sectional Study from a Tertiary Care Hospital in Gujarat
...
Published: 02/08/2025
Original Article
An analysis of Morphometric characteristics of Supratrochlear foramen of humerus
Published: 08/06/2025
Original Article
Outcomes of Plastic Surgical Reconstruction of Diabetic Foot Ulcers Following Systemic Optimization and Local Infection Control: A Prospective Study
...
Published: 08/06/2025
Research Article
Comparative Study of Oral Levamisole versus Oral Betamethasone in Vitiligo: A Prospective Analysis.
...
Published: 28/06/2025
© Copyright Spejalisci Dermatolodzy